1. Home
  2. RVYL vs SNOA Comparison

RVYL vs SNOA Comparison

Compare RVYL & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVYL
  • SNOA
  • Stock Information
  • Founded
  • RVYL 2007
  • SNOA 1999
  • Country
  • RVYL United States
  • SNOA United States
  • Employees
  • RVYL N/A
  • SNOA N/A
  • Industry
  • RVYL Professional Services
  • SNOA Biotechnology: Pharmaceutical Preparations
  • Sector
  • RVYL Consumer Discretionary
  • SNOA Health Care
  • Exchange
  • RVYL Nasdaq
  • SNOA Nasdaq
  • Market Cap
  • RVYL 5.4M
  • SNOA 6.4M
  • IPO Year
  • RVYL N/A
  • SNOA 2007
  • Fundamental
  • Price
  • RVYL $0.85
  • SNOA $2.90
  • Analyst Decision
  • RVYL Hold
  • SNOA
  • Analyst Count
  • RVYL 1
  • SNOA 0
  • Target Price
  • RVYL N/A
  • SNOA N/A
  • AVG Volume (30 Days)
  • RVYL 34.6M
  • SNOA 33.3K
  • Earning Date
  • RVYL 08-12-2025
  • SNOA 06-17-2025
  • Dividend Yield
  • RVYL N/A
  • SNOA N/A
  • EPS Growth
  • RVYL N/A
  • SNOA N/A
  • EPS
  • RVYL N/A
  • SNOA N/A
  • Revenue
  • RVYL $54,357,000.00
  • SNOA $14,288,000.00
  • Revenue This Year
  • RVYL $27.50
  • SNOA $38.54
  • Revenue Next Year
  • RVYL $35.71
  • SNOA N/A
  • P/E Ratio
  • RVYL N/A
  • SNOA N/A
  • Revenue Growth
  • RVYL N/A
  • SNOA 12.20
  • 52 Week Low
  • RVYL $0.36
  • SNOA $1.75
  • 52 Week High
  • RVYL $2.40
  • SNOA $9.37
  • Technical
  • Relative Strength Index (RSI)
  • RVYL 52.78
  • SNOA 38.85
  • Support Level
  • RVYL $0.60
  • SNOA $2.81
  • Resistance Level
  • RVYL $0.91
  • SNOA $3.45
  • Average True Range (ATR)
  • RVYL 0.10
  • SNOA 0.13
  • MACD
  • RVYL 0.02
  • SNOA -0.05
  • Stochastic Oscillator
  • RVYL 57.41
  • SNOA 10.77

About RVYL Ryvyl Inc.

Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

Share on Social Networks: